Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | SCF | 30.0 | 30 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | SCF | 44.0 | 49 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | SCF | 40.0 | 61 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | SCF | 34.0 | 53 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | SCF | 31.0 | 62 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | SCF | 29.0 | 56 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | SCF | 35.0 | 28 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | SCF | 40.5 | 50 | ||||
RA2159 | 2 | SCF | 43.0 | 35 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | SCF | 26.0 | 39 | ||||
N2645 | 2 | SCF | 32.5 | 52 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | SCF | 30.0 | 47 | ||||
RA2708 | 2 | SCF | 26.5 | 36 | |||||||
0 | SCF | 29.0 | 35 | ||||||||
0 | SCF | 28.0 | 47 | ||||||||
0 | SCF | 34.0 | 35 | ||||||||
0 | SCF | 25.0 | 40 | ||||||||
0 | SCF | 21.5 | 58 | ||||||||
0 | SCF | 27.0 | 46 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCF | 45.0 | 47 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | SCF | 46.0 | 49 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCF | 32.0 | 75 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | SCF | 36.0 | 61 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCF | 47.0 | 54 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | SCF | 46.0 | 61 |